Please Wait
Applying Filters...
menu
    • menu
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    MOR202

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    MorphoSys and I-Mab Sign Strategic Partnering Agreement for MOR210
    MorphoSys and I-Mab Sign Strategic Partnering Agreement for MOR210

    19 Nov 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/morphosys-and-i-mab-sign-strategic-partnering-agreement-for-morphosyss-novel-immuno-oncology-agent-mor210-300751272.html

    PR NEWSWIRE
    19 Nov 2018
    Share Share
    MorphoSys, I-Mab Sign Strategic Partnering Agreement for MOR210
    MorphoSys, I-Mab Sign Strategic Partnering Agreement for MOR210

    19 Nov 2018

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/morphosys-and-i-mab-sign-strategic-partnering-agreement-for-morphosyss-novel-immuno-oncology-agent-mor210-300751272.html

    PR NEWSWIRE
    19 Nov 2018
    Share Share
    I-Mab Biopharma, MorphoSys declares China IND Submission of monoclonal antibody
    I-Mab Biopharma, MorphoSys declares China IND Submission of monoclonal antibody

    08 Aug 2018

    // BIOSPECTRUM

    https://www.biospectrumasia.com/news/25/11468/i-mab-biopharma-morphosys-declares-china-ind-submission-of-monoclonal-antibody-.html

    BIOSPECTRUM
    08 Aug 2018
    Share Share
    FiercePharmaAsia—Sanofi, Takeda, I-Mab and more
    FiercePharmaAsia—Sanofi, Takeda, I-Mab and more

    06 Jul 2018

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma-asia/fiercepharmaasia-sanofi-s-chengdu-r-d-hub-takeda-s-osaka-hq-sale-i-mab-s-220m-financing

    Angus Liu FIERCE PHARMA
    06 Jul 2018
    Share Share